3-dihydrobenzo-(d)oxazol-5-yl)phenyl)ethyl)-1 Uses, Dosage, Side Effects and more
3-dihydrobenzo-(d)oxazol-5-yl)phenyl)ethyl)-1 is under investigation in clinical trial NCT03218917 (Assessment of INS1007 in Subjects With Non-cystic Fibrosis Bronchiectasis).
| Attribute | Details |
|---|---|
| Trade Name | 3-dihydrobenzo-(d)oxazol-5-yl)phenyl)ethyl)-1 |
| Generic | Brensocatib |
| Brensocatib Other Names | (S)-N-((S)-1-Cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo-(d)oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide, Brensocatib |
| Type | |
| Formula | C23H24N4O4 |
| Weight | Average: 420.469 Monoisotopic: 420.179755269 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
